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SUMMARY. Over the past few years, the rising rate of multiple pregnancies, attributed to both increasing reliance on
infertility treatment modalities and delayed childbearing, has expanded the need for prenatal invasive genetic testing. In
multiples, first-trimester chorionic villus sampling and second-trimester amniocentesis are relatively safe and efficient
alternative procedures, whereas fetal blood sampling is reserved for cases where an indefinite result of fetal karyotyping
needs elucidation. The choice of invasive technique should be based on gestational age at referral date, procedure related
risks and technical demands, but experience of the center performing the modality should be emphasized in decision
making. Technological advances in modern high resolution ultrasound equipment along with increasing operator
experience available today result in more accurate and efficacious invasive prenatal diagnosis in twin or higher-order
pregnancies, minimizing potential post-procedural fetal loss rate.
Pregled
Klju~ne rije~i: genetsko testiranje, vi{eplodna trudno}a, prenatalna dijagnostika
SA@ETAK. Monozigotni blizanci ~ine oko 30% blizana~kih trudno}a, njihova je u~estalost stalna, a dvozigotni blizanci
~ine oko 70% blizana~kih trudno}a, njihova je u~estalost u porastu, zbog u~estale primjene tehnike pomognute oplodnje i
zbog odga|anja prvih trudno}a te posljedi~ne ve}e `ivotne dobi trudnica. Rizik strukturalnih anomalija u blizanaca je
ve}a nego u jednoplodnih trudno}a, rizik je do tri puta ve}i u monozigotnih, a u dizigotnih blizanaca je od prilike kao u
jednoplodnih trudno}a. Zbog ukupno ve}e u~estalosti vi{eplodnih trudno}a pove}ana je potreba za invazivnom prenatal-
nom dijagnostikom. U vi{eplodnim trudno}ama su biopsija korionskih resica u prvom i amniocenteza u drugom
tromjese~ju relativno sigurni i uspje{ni alternativni postupci, a uzimanje fetalne krvi kordocentezom je rezervirano za
slu~ajeve kada je u~injena kariotipizacija fetusa nesigurna i nejasna. Izbor invazivne tehnike se temelji na dobi trudno}e
kad se trudnica javlja, na postoje}i rizik postupka i na tehni~ke zahtjeve, a od velikog je zna~aja iskustvo prenatalnog
centra. Tehnolo{ki napredak suvremene ultrazvu~ne aparature te rastu}e iskustvo prenatalnog operatera doprinose to~noj
i u~inkovitijoj invazivnoj prenatalnoj dijagnostici u dvojaka i blizanaca vi{eg stupnja te na najmanju mogu}u mjeru
smanjuju fetalni gubitak nakon invazivnog postupka.
Introduction
The prevalence of multiple pregnancy varies world-
wide from 6.7 per 1000 deliveries in Japan to 40 per
1000 deliveries in Nigeria. The respective prevalence in
Europe and North America is estimated to be 11 per
1000 deliveries. The incidence of multiple births has in-
creased dramatically over the past three decades since in
vitro fertilization (IVF) was first introduced in modern
obstetrics and gynaecology. Tremendous advances
achieved in assisted reproductive techniques (ART) in-
cluding IVF and non-ART procedures such as ovulation
induction, rendered infertility treatment increasingly
popular among infertile and subfertile couples. It has
been postulated that women undergoing ovulation in-
duction have an approximately 6% chance of conceiv-
ing multiples.
1
Furthermore, implementation of ART is
accompanied by a 35% chance or more of accomplish-
ing twin or higher-order pregnancy.
2
Hence, increasing
reliance on assisted conception modalities noted nowa-
days, has been considered the major causative factor of
the rising rate of multiple pregnancies. In a lesser de-
gree, delayed childbearing in progressively advanced
maternal age currently adopted by many prospective
mothers accounts for the rising rate of spontaneously
conceived multiplets.
There is no doubt that infertility treatment is associ-
ated with an increase in the rate of monozygotic (MZ)
twins to greater than 10-fold, the latter being at high risk
of functional and structural abnormalities, affecting
10–15% of these twins.
3–5
On the other hand, the inci-
dence of chromosomal abnormalities is strongly related
to maternal age. Available data confirms that twin preg-
nancies per se are at increased risk for fetal chromo-
somal abnormalities than those with singletons.
6,7
The-
refore, the increasing incidence of multiple pregnancies
illustrates a concomitant increase in the need for inva-
sive genetic testing in these pregnancies.
Zygocity and chorionicity
It is widely accepted that the number of fetuses itself
does increase possible maternal and fetal risks and
16
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thereby the potential of an adverse pregnancy outcome.
However, the cornerstone in prenatal diagnosis, surveil-
lance and management of a multiple gestation is cho-
rionicity as well as zygocity determination. Chorionicity
refers to the placentation whereas zygocity implies the
genetic profile of the pregnancy and therefore deter-
mines the degree of risk and whether or not the fetuses
may be concordant or discordant for chromosomal ab-
normalities.
It is estimated that more than 30% of twins are identical
or MZ and nearly 70% are fraternal or dizygotic (DZ).
Monozigotic twins originate from the division of a single
fertilized ovum with an incidence rate of about 3.5/1000
pregnancies.
8
The rate of spontaneous MZ twin pregnan-
cies is constant contrary to the increased frequency re-
ported among pregnancies derived from infertility treat-
ment modalities. MZ twins may be dichorionic diam-
niotic (DC-DA), monochorionic diamniotic (MC-DA),
monochorionic monoamniotic (MC-MA), and even con-
joined, determined by the period of embryonic develop-
ment when zygotic splitting takes place. In about 20–30%
of cases, splitting occurs within three days of fertilization
resulting in separate fetuses with independent placental
circulations, therefore being DC-DA, even if placentas
may seem to be in continuity or fused. In the majority of
cases (about 70%) splitting occurs within the first week
but later than the third day, it results in a single mono-
chorionic plate and two distinct amniotic sacs, hence
MC-DA twins originate. Delayed zygotic splitting leads
to MC-MA twins, accounting for 1% of MZ twins,
though later than 13
th
day is extremely rare, resulting in
the formation of the abnormal conjoined (Siamese) twins.
Dizygotic twins arise from the fertilization of two
distinct ova, thus may be of the same or different sex.
Each twin has its own placenta and amniotic sac
(DC-DA). Very infrequent cases of MC-DZ twins origi-
nating from the fusion of two separate blastocysts have
been recently reported in association with ART,
9
stag-
gering the categorical general rule by far having been
accepted in obstetrics that MC twins are exclusively
MZ.
10
The incidence rate of DZ twins varies signifi-
cantly, influenced by race (higher in blacks, lower in
Asians), heredity, maternal age (peak between 35–40
years of age), history of previous DZ twin pregnancy,
nutrition habitus and anthropometric features (height
and weight) of the woman.
ART including in vitro fertilization and non ART pro-
cedures such as ovulation induction and subsequent
intrauterine insemination using human pituitary gonad-
otrophic hormones increase the incidence of multiple
pregnancy, both MZ and DZ, while clomiphene citrate
increases the occurrence rate of DZ pregnancies to about
5–10%.
3–5,11
It should be emphasized the general aspect that the in-
cidence of multiple pregnancies is correlated with in-
creasing maternal age stands for DZ twins. It is well es-
tablished that the frequency of MZ twinning remains rel-
atively constant, independent of the age of the woman.
The risk of structural anomalies
in multiple gestations
The incidence of structural anomalies in twins is
higher compared to singletons. However, the frequency
of malformations in DZ twins is thought to be similar to
that of singletons (2–3%) contrary to that observed to
MZ, which has been reported to be 2–3 times higher.
12
The exact underlying mechanism of the increased prev-
alence of structural defects in MZ twins remains ob-
scure, although the teratogenic nature of the twinning
process itself and vascular events occurring during
intrauterine development may account for part of them.
Of interest, concordance (both fetuses similarly af-
fected) for a structural anomaly, even in MZ twins, is
rare (less than 20%).
13
Neural tube defects, anencephaly, holoprosencephaly,
sirenomelia complex, cloacal exstrophy and abnormali-
ties that fit into the expanded VATER/VACTERL asso-
ciations are more common in MZ twins. However, the
risk of fetal abnormalities in twins may be biased, be-
cause multiple pregnancies are intensively scanned, in-
creasing the chances of detecting underlying anomalies.
Moreover, twinning is much more common in women of
advanced age, in whom prenatal screening is more likely
to yield the diagnosis of fetal defects as far as aging is as-
sociated with increased risk for fetal abnormalities.
The risk of chromosomal abnormalities
in multiple gestations
Inasmuch as zygocity represents the genetic make-up
of the developing entity, accurate determination of this
parameter is considered a prerequisite in multiple preg-
nancy prenatal screening for aneuploidies. In the clinical
setting, zygocity is usually inferred from the ultrasound
diagnosis of chorionicity,
6
the latter best achieved in the
first trimester. In DA pregnancies with fused placentas,
measurements of the thickness of the dividing mem-
brane using a cut-off value of 2 mm can differentiate
MC from DC twinning, though a high inter and intra-ob-
server variability has been reported. Sonographic detec-
tion of the »lambda« or »twin peak« sign is reported as a
more reliable indicator of DC placentation with an accu-
racy of 100% at 10–14 weeks’ gestation.
14
Delayed in
the second trimester sonographic evaluation is associ-
ated with a 10–12% chorionicity misinterpretation
rate,
15,16
while after 20 weeks’ gestation the determina-
tion may turn out impossible. Therefore, in the absence
of the »lambda« or »twin peak« sign in a DA twin preg-
nancy, single placentation and monozygocity is con-
cluded, when the rare cases of MC-DZ gestations fol-
lowing ART reported are not taken into consideration.
However, when a single amniotic sac is detected,
monochorionicity is indisputable. Given that the great
proportion (80–90%) of DC twins are DZ,
17,18
chorio-
nicity may roughly correspond to zygocity.
19
MZ twins are almost always of the same sex and ge-
netically identical and therefore the risk for chromo-
17
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somal abnormalities does not differ from that in single-
tons. Very infrequently, postzygotic mitotic events
(nondisjuction or anaphase lag) or prezygotic meiotic
errors can cause genetic discordance between MZ sib-
lings, involving mosaicism, skewed-X-inactivation, dif-
ferential gene imprinting and small scale mutation.
20
Heterokaryotypic monozygotism is used to define the
rare karyotypic discordance, most commonly expressed
by one fetus affected by Turner syndrome whereas the
other presents either a normal male or normal female
karyotype.
21–23
MZ discordance for trisomy 21, Kline-
felter syndrome, Patau syndrome, trisomy 1 and 22q11
deletion syndrome has also been described.
23–27
How-
ever, these unusual discrepancies are not taken into con-
sideration when calculating aneuploid risk, though
should always be assumed when invasive prenatal diag-
nosis is performed in MC-DA twins dictating sampling
from both sacs.
In DZ twins, each embryo has an independent risk for
aneuploidy and therefore the risk that at least one fetus
being affected will be almost twice the maternal age risk
for a singleton (e.g. in respect to trisomy 21, for a
40-year-old woman, 1/100+1/100=1/50). The probabil-
ity of both fetuses being involved is minimal (1/100x
1/100=1/10,000).
17
In cases with uncertain chorionicity
and thus zygocity, aneuploidy risk assessment requires
an estimation of the most likely zygocity, which may
vary according to maternal age and race. In general,
given that one-third of all twin pairs are monozygotic,
the risk for one twin being aneuploid in case of unknown
zygocity is calculated to five-thirds that of the singleton
risk.
15,19
Based on these estimations, a 33-year-old wo-
man bearing twins has a risk for at least one aneuploid
offspring, comparable to the risk of a 35-year-old wo-
man bearing a singleton. On this assumption, such
women should be offered prenatal testing.
28
However,
despite these aspects, reported series show a lower risk
for fetal chromosomal abnormalities in live-born twins.
Prenatal screening for fetal anomalies
in multiples
Unambiguously, it has been a common practice to ex-
trapolate data derived from singletons to multiples.
However, implementation of ultrasound as well as ma-
ternal serum analyse screening for fetal abnormalities in
twin or higher-order pregnancies, seems to be more
complex. Cautious interpretation of screening results is
considered mandatory in order to minimize possible er-
roneous high false positive rate and subsequent high rate
of undue invasive procedures.
Given that chorionicity has been definitely determi-
ned, in DC multiple pregnancies, first-trimester ultra-
sound scan offer an invaluable aid in fetal risk assess-
ment for chromosomal abnormalities. In particular, fetal
nuchal translucency (NT) screening has yielded compa-
rable results regarding detection rates as well as false
positive rates with singleton pregnancies.
29
In MC twins, a cautious evaluation of increased NT
thickness should be reserved in respect to the possible
early twin-to-twin transfusion syndrome (TTTS) origin
of this finding. A rational approach has been proposed to
be the application of the average value of NT measure-
ment of both fetuses in risk assessment in an effort to re-
duce misinterpretation.
30
The inability to determine the degree to which each fe-
tus contributes to the overall maternal biochemistry level
may reflect a significant shortcoming in first trimester
biomarkers’ sensitivity and specificity in multiple gesta-
tions. Nevertheless, the altered biochemical markers of
the aneuploid fetoplacental unit are partly masked by the
normal biochemical profile of the euploid co-twin.
Since the application of maternal biochemistry in risk
assessment for aneuploides in twin or higher-order mul-
tiple gestations remains arguable, ultrasound scan has
been proven of great value for early determination of
chorionicity and subsequent standardized NT measure-
ment as well as genetic sonogram targeting to illuminate
possible sonographic markers of fetal aneuploidy.
Invasive procedures for prenatal diagnosis
It is uniformly accepted that invasive procedures for
fetal karyotyping in twins or higher-order multiplets are
more challenging than in singletons. First-trimester cho-
rionic villus sampling (CVS) and second-trimester am-
niocentesis are alternative techniques requiring experi-
enced hands to ensure sampling both fetuses and mini-
mize procedure related risks. Fetal blood sampling for
genetic studies is rarely used today.
Amniocentesis
Genetic amniocentesis performed later than 15 weeks
of gestation has been proven a safe and accurate proce-
dure for sampling all fetuses of a multiple gestation.
Currently, there is little information regarding the risk of
amniocentesis between 13 and 15 weeks though this in-
vasive procedure has been associated with increased
risk for fetal loss, amniotic fluid leakage and fetal talipes
equinovarous and therefore is not recommended.
15,31,32
Amniocentesis in twins can be reached through a sin-
gle or double uterine entry. Three methods of tapping
multiple sacs have been described so far. One of them
uses the single whereas the remaining two use the dou-
ble uterine entry approach. Each technique can be per-
formed either freehand or with a needle guide.
The first one, initially described by Elias et al in 1980,
involves two or more needle insertions, one for each sac,
also called the double needling technique or technique
of double amniocentesis.33 In a twin or higher-order
multiple pregnancy, two or more 22 gauge 3.5 inch
spinal needles are separately and sequentially inserted
transabdominally under ultrasound visualization into
each sac and about 20 ml of amniotic fluid is readily as-
pirated and sent for cytogenetic evaluation or fetal
karyotyping. A problem not infrequently faced with this
18
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technique is erroneously sampling twice the same
amniotic sac. In order to eliminate this possibility, the
sampled sac is marked with a blue dye ensuring that the
sac is tapped only once. For this purpose indigo carmine
has been successfully used without any adverse ef-
fects,
34
though a mild vasoconstrictive effect following
intravenous injection has been described. However, the
instillation of a foreign substance into the amniotic cav-
ity is of concern. A technical disadvantage with the in-
stillation of indigo carmine is that the dye tends to con-
centrate at the bottom of the sac taking some time before
the stained fluid surrounds the fetus. Methylene blue
used as a marker dye in the past has been linked to cer-
tain toxic manifestations such as fetal hemolysis, fetal
small bowel atresias and fetal death.
35–40
Nevertheless,
the high resolution ultrasound equipment currently
available, in expertise hands, may ensure accurate sam-
pling from each sac,
41,42
reserving the installation of dye
for cases of amniotic volume discordance where detec-
tion of the septum is uncertain or high-order pregnancies
where documentation and »labeling« of sacs turn out in-
secure.
43
An alternative approach first described by Jeanty et
al. in 1990 is the single uterine entry technique or sin-
gle needle insertion technique.44 The needle entry is
made into the proximal sac near the insertion of the di-
viding membrane and 20 ml of amniotic fluid are re-
trieved. After the stylet is replaced, the needle is ad-
vanced through the second sac under direct ultrasound
guidance. In order to avoid contamination the first few
milliliters of amniotic fluid are discarded and aspiration
of 20 ml from the second sac integrates the procedure.
Many advantages linked to this technique have been re-
ported: requiring only one needle insertion and being
swifter and shorter reduces woman’s discomfort as well
as the risk of post-procedural complications. Moreover,
advancing the needle through the septum between the
two sacs under ultrasound guidance provides positive
proof of tapping both of them, diminishing the need for
dye insertion. However, potential disadvantages render
this approach less popular. Possible contamination of
the second sample with amniotic fluid and fetal cells
from the first one, may lead to an incorrect diagnosis of
mosaicism in the second fetus. This complication can be
avoided by strictly adhering to the technique, by replac-
ing the stylet prior to intertwin membrane penetration
and by discarding the first few milliliters from the sec-
ond sac. Besides, the possibility of converting DA to
pseudo-MA twin pregnancy with the correspondence
risks for cord entanglement and the formation of the
amniotic band syndrome cannot be precluded.
45
In addi-
tion, a technical difficulty in penetrating a »tenting« di-
viding membrane has been reported.
Two years later, in 1992, the double simultaneous vi-
sualization technique or double simultaneous amnio-
centesis, was introduced by Bahado-Singh et al.46 This
technique involves two needles inserted separately into
the amniotic sacs under ultrasound visualization like in
the technique of double amniocentesis. The difference
is that after aspiration of the amniotic fluid from the first
sac, the needle is left in place indicating the sampled
cavity and the second insertion is made into the other
sac. The main advantage seems to be the documentation
of correct sampling from each sac. However, it is not
widely used mainly because it is more time consuming
and thereby the experience with this approach is limited.
Prenatal diagnostic invasive procedures and thus am-
niocentesis must be preceded by a detailed ultrasound
evaluation of the multiple pregnancy involving cho-
rionicity and amnionicity determination and documenta-
tion of the location of the placenta(s). Moreover, relative
position, size, anatomy and gender (if possible) consist-
ing distinguishing features of each fetus should be speci-
fied, and »labeling« of the multiples using text and dia-
gram should be performed to ensure correct sampling
from each of them. Recently, the role of amniotic fluid al-
pha-fetoprotein (AFAFP) values was evaluated in confir-
mation of both sacs in a DC pregnancy being sampled.
47
Concern regarding potential post-amniocentesis in-
crease in fetal loss rate in multiples has led to a plethora
of studies evaluating this parameter. Early reports sug-
gested a higher fetal loss rate in twin pregnancies than in
those with singletons.
48–50
However, these studies did
not take into account the possibility that the increased
fetal wastage might be attributed to the twin pregnancy
itself rather than the invasive procedure. Later on, it was
reported that the maternal history of twins per se carries
a pregnancy loss rate up to 24 weeks of about 6.3% and
severe prematurity (24–28 weeks) rate of about 8%.
51
Most series of single pregnancy outcome following sec-
ond-trimester amniocentesis report loss rates before 20
weeks’ gestation of between 1% and 2.5% and a much
higher loss rate before 28 weeks. In a multicenter Euro-
pean study, the pregnancy loss rate was estimated to be
2.3% and 3.7% before 20 and 28 weeks’ gestation re-
spectively.
52
In a case control study, a similar fetal loss
rate was reported between sampled twins and unsam-
pled matched twin controls (3.5% vs 3.2%).
53
In conclusion, amniocentesis in twin pregnancies is
thought to be a relative safe and accurate diagnostic pro-
cedure providing that sampling involves both sacs re-
gardless the zygocity and chorionicity.
Chorionic villus sampling
CVS, also called placental biopsy, is a safe alternative
invasive procedure to amniocentesis for prenatal diag-
nosis in multiples.
54–56
The major advantage of CVS is
early diagnosis, obtained in the first trimester of preg-
nancy. In particular, genetic results are feasible either
within hours by direct preparations of the cytotropho-
blast layer, or within 3–7 days by tissue culture of chori-
onic villus mesenchymal core. Early diagnosis provides
earlier reassurance of fetal well being and thereby elimi-
nates both maternal anxiety and uncertainty. On the
other hand, the diagnosis of one or both abnormal twins
allows subsequent selective reduction of the affected fe-
tus or surgical termination of pregnancy rather than
19
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medical induction of labour as early as in the first tri-
mester where complication rates are lower. Moreover,
fetal reduction performed earlier in pregnancy may be
associated with a higher survival rate of the unaffected
twin.
57
In terms of privacy and maternal psychology, the
earlier an abnormal pregnancy is terminated the lesser
the chance of being widely recognized.
CVS is best performed between 11 and 13 weeks’ ges-
tation. Data derived from singleton pregnancies illustrate
an association of CVS performed earlier in pregnancy
and fetal transverse limb abnormalities, micrognathia and
microglosia. In general, first-trimester CVS in multiple
gestations is technically more demanding than second-
-trimester amniocentesis. Transabdominal as well as
transcervical approach have been used. Some suggest
that the highest success rates are achieved when the clini-
cian is comfortable using either technique. Transcervical
CVS is performed either by an aspiration catheter or by a
biopsy forceps. Technically, it may be more difficult to
perform and the »learning curve« appears to involve
many patients. Transabdominal approach uses an aspira-
tion needle and is technically more similar to second-tri-
mester amniocentesis and thus more familiar to the ma-
jority of obstetricians. Both techniques can be performed
either freehand or with a needle guide.
Continuous ultrasound visualization of the tip of the
needle, catheter or biopsy forceps is essential to ensure
sampling both chorions. If in doubt, a follow-up proce-
dure should be performed either by an immediate repeat
CVS or by second-trimester amniocentesis. A serious
drawback of CVS is potential contamination of one
sample by villi belonging to the other chorion or less fre-
quent by maternal cells. At that case, a confusing or even
misleading diagnosis is unfortunately possible. Al-
though early studies suggested a contamination rate as
high as 4%, more recent studies report a much lower
rate, almost nullified.
58,59
Still, Weisz and Rodeck sug-
gest that it would be prudent to counsel patients that
about 2–3% of twin pregnancies having CVS will need
re-sampling because of uncertainty of results.
43
In rare cases, the combination of transcervical and
transabdominal approach along with the increasing cli-
nician experience available today can eliminate such an
unfortunate possibility. Furthermore, obtaining samples
adjacent to the cord insertion site far away from the di-
viding membrane is reasonably recommended.
Genetic counseling must include the possibility of a
discordant abnormal result necessitating cautious inter-
pretation. Therefore, detailed documentation and »la-
beling« of the fetuses and the chorions is equally as im-
portant with CVS as it is with amniocentesis. Although
the position of sacs will remain unchanged during the
2–3 weeks-time following sampling, it is standard prac-
tice to re-confirm the original diagnosis in both fetal and
chorionic tissues before selective reduction of the af-
fected twin.
The estimated risk of CVS-associated fetal loss in sin-
gletons varies widely (1.3–4.3%). Two or more sam-
plings during one procedure have been linked to in-
creased risk of post-procedural miscarriage,
60,61
implying that the risk may be higher in twin sampling.
Overall an estimated risk of 2–4% in twin pregnancies
has been reported. However, available data demonstrate
significant variations. In one study, the risk of CVS-as-
sociated fetal loss before 28 weeks’ gestation did not
seem to differ between twin and singleton pregnancies
(4.9 vs 4%).
54
When only chromosomal normal preg-
nancies are considered, the overall loss rate found in a
study of 202 twin pregnancies that underwent CVS be-
came 3.7%, a figure that is considerably less than that of
amniocentesis.
54
In another study, the pregnancy loss
rate before 20 weeks following CVS was found 3.3%
comparable to 2.8% in a control group of twin pregnan-
cies undergone amniocentesis. Hence, it may be claimed
that in experienced centers, CVS is as safe as amniocen-
tesis for sampling twins.
The choice of invasive technique for fetal karyo-
typing should depend on the procedure related risks, on
accuracy of obtaining a result from both fetuses, on
technical demands and on clinicians’ experience. Gesta-
tional age at referral date may be crucial in decision
making. Eventually, is there a clear benefit of perform-
ing CVS than amniocentesis or vice versa that would
render one procedure by far superior than the other? The
answer is absolutely no. Amniocentesis is technically
easier and widely adopted, whereas CVS’s results are
available about one month earlier, thus therapeutic as
well as selective terminations are safer. However, it
should be emphasized that if the prenatal center is not
skilled and experienced in CVS, amniocentesis should
be preferred. A rational approach may be as follows: the
choice of invasive technique should be based on individ-
ual risk calculated from the combination of maternal age
and fetal NT thickness measured in the first trimester.
When the risk for a chromosomal defect, in at least one
of the fetuses, is greater than 1 in 50, it may be prefera-
ble to perform CVS. For pregnancies with a lower risk,
amniocentesis after 15 weeks may be more appropriate.
Fetal blood-sampling
Fetal cordocentesis for prenatal genetic testing has
been previously used to validate abnormal findings in
amniocentesis or CVS. It has also been used in case that
a rapid chromosomal diagnosis (rapid karyotyping) was
pending, since the results are offered in 2–3 days-time.
Nowadays, novel molecular techniques allow accurate
rapid karyotype determination thereby limiting fetal
blood sampling’s application.
Likewise in singletons, cordocentesis in multiples is
technically challenging requiring skilled operators with
extensive experience in other invasive ultrasound-gui-
ded needle procedures, such as amniocentesis and CVS.
Umbilical cord is usually punctured proximal to its in-
sertion into the placenta. A needle guide or freehand
technique may be used.
In a study conducted in 2003, involving 84 twin preg-
nancies, mainly screened for hemoglobinopathies, the
20
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overall procedure-related fetal loss (up to 2 weeks post-
procedurally) was 8.2%, about fourfold higher than the
correspondence risk in singletons. However, this tech-
nique can be used as an alternative to amniocentesis af-
ter 20 weeks’ gestation to confirm an abnormal karyo-
type in a DC pregnancy, when selective feticide is con-
sidered a few weeks after the initial procedure.
62
Conclusions
In conclusion, the rising rate of multiple pregnancies
mainly attributed to the widely use of infertility treatment
modalities has increased the need for invasive genetic
studies in these pregnancies. Diagnosis of fetal aneu-
ploidies and genetic defects can be achieved either by
first-trimester CVS or by second-trimester amniocente-
sis, whereas it is postulated that they are equally safe in
experienced hands. The choice of invasive procedure in
multiple pregnancies depends on several factors, but the
experience of the center performing the modality should
be emphasized in decision making. The indications of fe-
tal blood sampling are currently limited and progres-
sively surrogated by novel molecular techniques imple-
mented in CVS or amniocentesis’ specimen. High reso-
lution ultrasound equipment available today, along with
increasing operator experience gained throughout the
years, results in more accurate and efficacious invasive
prenatal diagnosis in twin or higher-order pregnancies,
minimizing potential post-procedural fetal loss rate.
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